By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The NextGen Group today said that revenues for the first half of the year increased 34 percent, leading to a decline in its net loss.

For the six months ending June 30, the company recorded $948,279 in revenues, up from $708,831 a year ago. Its net loss for the period improved to $1.6 million, or $.0002 per share, from $1.7 million, or $.0004 per share, from the first half of 2010.

NextGen ended the half-year with $28,533 in cash and cash equivalents.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.